MedTrace Logo

Pharmacy Delivery to Expand the Reach of PrEP in Kenya

NCT04558554 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1216

Last updated 2024-03-15

Study results available
· View outcomes & findings →

Summary

3 consecutive studies to test a novel model for PrEP initiation and refills in Kenya: pharmacy-based PrEP delivery.

Conditions

  • HIV Prevention

Interventions

OTHER

pharmacy-based PrEP delivery

The intervention is a new model of PrEP delivery that has never been tried before in an African setting: pharmacy-based PrEP delivery.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • University of Washington

    lead OTHER

Principal Investigators

  • Katrina Ortblad, MPH, ScD · University of Washington

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-26
Primary Completion
2022-07-31
Completion
2022-07-31

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04558554 on ClinicalTrials.gov